Editing Thygeson's superficial punctate keratopathy (section)

== Treatment ==
There are a number of different treatments to deal with TSPK. Symptoms may disappear if untreated, but treatment may decrease both the healing time and the chances of [[Remission (medicine)|remission]].{{cn|date=September 2022}}
* Artificial tear eye-drops or ointments may be a suitable treatment for mild cases.
* Low-dosage [[steroid]]al eye-drops, such as [[prednisone]], [[fluorometholone]], [[loteprednol]] (Lotemax 0.5%) or [[rimexolone]]. Steroidal drops should be used with caution<ref name="pmid10571306">{{cite journal | vauthors = Tanzer DJ, Smith RE | title = Superficial punctate keratitis of thygeson: the longest course on record? | journal = Cornea | volume = 18 | issue = 6 | pages = 729–730 | date = November 1999 | pmid = 10571306 | doi = 10.1097/00003226-199911000-00017 }}</ref> and the eye pressure should be regularly checked during treatment.
* Soft [[contact lens]]es.
* [[Ciclosporin]] is an experimental treatment for TSPK. It is usually used during [[Organ transplant|transplant]]s as it reduces the [[immune system]] response.
* [[Tacrolimus]] (Protopic 0.03% ointment) is also an experimental treatment.
* [[Laser eye surgery|Laser eye treatment]].<ref>{{cite journal | vauthors = Noble J, Boerman H, Jiang W, Martén L, McCormick GJ, Pepose JS, Solomon R, Yeu E | title = Peer-Reviewed Literature: The Treatment of Thygeson's Superficial Punctate Keratitis | date = June 2007 | journal = Cataract & Refractive Surgery Today | pages = 21–23 }}</ref>
* [[Amniotic membrane]] (Case Study)<ref>{{cite journal | vauthors = Kobayashi A, Yoshita T, Sugiyama K, Miyashita K, Niida Y, Koizumi S, Tseng SC | title = Amniotic membrane transplantation in acute phase of toxic epidermal necrolysis with severe corneal involvement | journal = Ophthalmology | volume = 113 | issue = 1 | pages = 126–132 | date = January 2006 | pmid = 16324747 | doi = 10.1016/j.ophtha.2005.09.001 }}<!--|access-date=9 December 2012--></ref>
* PRK laser eye surgery has been suggested in a one-person case study as having cured this disease.<ref>{{cite journal | vauthors = Goldstein MH, Feistmann JA, Bhatti MT | title = PRK-pTK as a treatment for a patient with Thygeson's superficial punctate keratopathy | journal = The CLAO Journal | volume = 28 | issue = 4 | pages = 172–173 | date = October 2002 | pmid = 12394540 | doi = 10.1097/01.ICL.0000024359.29208.59 | doi-broken-date = 1 November 2024 | s2cid = 23076934 }}</ref>